Transplant trial for severe aplastic anemia with related donor
Treatments studied
Part of Blood & lymphatic clinical trials.
This Phase 2 study tests a bone marrow transplant from a closely matched related donor, plus medicine after the transplant to help prevent immune complications. It may be an option if you have severe aplastic anemia and meet specific health and lab requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aplastic anemia with low blood counts (meeting specific lab cutoffs)
- You have a related donor matched at HLA-A, B, and DR (about 3/6 to 5/6 match) with a negative cross-match
- Your age is 65 or younger if previously treated, or 75 or younger if previously treated
- Your overall performance status is good enough (KPS 70% or higher)
- You have acceptable heart, lung, liver, and kidney function based on set thresholds
- You have not had a prior bone marrow transplant from another person
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This Phase 2 study looks at doing a bone marrow transplant from a carefully matched donor right away in children with idiopathic aplastic anemia. It aims to improve chances of recovery using a donor that closely matches the patient when a sibling or family donor is not available.
This trial tests a stem cell transplant using a milder conditioning regimen and a drug called post-transplant cyclophosphamide to treat severe aplastic anemia and other acquired bone marrow failure conditions. The goal is to help patients achieve a functioning donor bone marrow with fewer side effects.
This trial tests a new way to prepare the body for a donor stem cell transplant (allogeneic transplant) in people with severe aplastic anemia or other blood diseases. The goal is to make the transplant safer and more effective.
This Phase 2 study tests a specific type of donor stem cell transplant for severe bone marrow failure conditions, aiming to improve cure rates while reducing transplant risks. It includes people with diseases like severe aplastic anemia and certain bone marrow disorders, especially when standard transplant plans feel too risky.
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Hear when a new Severe Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.